Clinical trials in Otopeni

Investigating innovative treatments for non-squamous non-small cell lung cancer (NSCLC), with a focus on patients exhibiting specific genetic markers like c-Met overexpression. Studies are evaluating the effectiveness of targeted therapies compared to standard treatments.

• EGFR wildtype NSCLC
• Treatment resistance patterns
• Targeted therapy approaches

Research aims to improve survival rates and treatment outcomes for lung cancer patients.

Comprehensive studies focusing on renal cell carcinoma and high-risk prostate cancer. Clinical trials are exploring combination therapies and novel treatment approaches including hormone therapy with radiation treatment.

• Advanced kidney cancer treatments
• Prostate cancer management
• Combination therapy efficacy

Research centers on improving disease-free survival and treatment outcomes.

Groundbreaking research in advanced melanoma treatment, investigating the potential of combination immunotherapy approaches. Studies are comparing various therapeutic combinations to establish optimal treatment protocols.

• Immunotherapy combinations
• Advanced melanoma management
• Treatment effectiveness markers

Focus on developing more effective first-line treatments for unresectable melanoma.